Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Rizzieri

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Leukemia|November 7, 2023
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AMLGuillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, et al.
Nature Cancer|June 6, 2022
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin H Lin, Justine C Rutter, Abigail Xie, et al.
Transplantation and Cellular Therapy|March 30, 2021
Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell TransplantationVinay K Giri, Kristin G Kegerreis, Yi Ren, et al.
JCO Oncology Practice|February 13, 2020
Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid LeukemiaJohn M Pagel, Megan Othus, Guillermo Garcia-Manero, et al.
JCO Oncology Practice|March 20, 2025
Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid LeukemiaJohn M Pagel, Megan Othus, Guillermo Garcia-Manero, et al.
British Journal of Haematology|July 9, 2013
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvementRichard T Maziarz, Zhiwei Wang, Mei-Jie Zhang, et al.
Nature Genetics|November 13, 2012
The genetic landscape of mutations in Burkitt lymphomaCassandra Love, Zhen Sun, Dereje Jima, et al.
Blood|July 31, 2008
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemiaStephanie J Lee, Manisha Kukreja, Tao Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
Genetic heterogeneity of diffuse large B-cell lymphomaJenny Zhang, Vladimir Grubor, Cassandra L Love, et al.
JAMA Oncology|September 15, 2017
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest GroupMei Guo, Nelson J Chao, Jian-Yong Li, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Leukemia|November 7, 2023
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AMLGuillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, et al.
Nature Cancer|June 6, 2022
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin H Lin, Justine C Rutter, Abigail Xie, et al.
Transplantation and Cellular Therapy|March 30, 2021
Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell TransplantationVinay K Giri, Kristin G Kegerreis, Yi Ren, et al.
JCO Oncology Practice|February 13, 2020
Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid LeukemiaJohn M Pagel, Megan Othus, Guillermo Garcia-Manero, et al.
JCO Oncology Practice|March 20, 2025
Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid LeukemiaJohn M Pagel, Megan Othus, Guillermo Garcia-Manero, et al.
British Journal of Haematology|July 9, 2013
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvementRichard T Maziarz, Zhiwei Wang, Mei-Jie Zhang, et al.
Nature Genetics|November 13, 2012
The genetic landscape of mutations in Burkitt lymphomaCassandra Love, Zhen Sun, Dereje Jima, et al.
Blood|July 31, 2008
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemiaStephanie J Lee, Manisha Kukreja, Tao Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
Genetic heterogeneity of diffuse large B-cell lymphomaJenny Zhang, Vladimir Grubor, Cassandra L Love, et al.
JAMA Oncology|September 15, 2017
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest GroupMei Guo, Nelson J Chao, Jian-Yong Li, et al.
Pageof 14